Related references
Note: Only part of the references are listed.Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
Julio Cruz-Chan et al.
SCIENTIFIC REPORTS (2021)
TLR4 agonist protects againstTrypanosoma cruziacute lethal infection by decreasing cardiac parasite burdens
Liliana E. Villanueva-Lizama et al.
PARASITE IMMUNOLOGY (2020)
A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection
Meagan A. Barry et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice
Juan Jose de la Cruz et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
Lucas Michel-Todo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease
Kathryn Jones et al.
INFECTION AND IMMUNITY (2018)
Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas Disease
Amadeo B. Biter et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico
Liliana E. Villanueva-Lizama et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism
Nazia Khatoon et al.
VACCINE (2018)
Conserved epitopes in variants of amastin protein of Trypanosoma cruzi for vaccine design: A bioinformatics approach
Parvez Singh Slathia et al.
MICROBIAL PATHOGENESIS (2018)
Multi-epitope vaccines: a promising strategy against tumors and viral infections
Lifang Zhang
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease
Christopher A. Seid et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy
Vanaja Konduri et al.
INFECTION AND IMMUNITY (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Theo Vos et al.
LANCET (2016)
Status of vaccine research and development of vaccines for Chagas disease
Coreen M. Beaumier et al.
VACCINE (2016)
Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi
Catherine W. Cai et al.
PLOS PATHOGENS (2016)
Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice
Viridiana Martinez-Campos et al.
VACCINE (2015)
From Genome Screening to Creation of Vaccine Against Trypanosoma cruzi by Use of Immunoinformatics
Christian Teh-Poot et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice Role of CD4+ and CD8+ T cells
Alberto Yairh Limon-Flores et al.
VACCINE (2010)
Modulation of chagasic cardiomyopathy by interleukin-4 - Dissociation between inflammation and tissue parasitism
MBP Soares et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
